Drug · DIN 02229437
PHOSLO TABLETS
No: no longer authorized
The company stopped selling it and its DIN was cancelled. A cancellation is most often a business decision; the record does not say why.
Status Cancelled Post Market since July 29, 2013; first marketed February 22, 2006.
- Drug Identification Number (DIN)
- 02229437
- Company (DIN owner)
- Fresenius Medical Care North AmericaWaltham, Massachusetts, United States
- Schedule
- Prescription
- Dosage form
- Tablet
- Route
- Oral
- Therapeutic class (ATC)
- Drugs for treatment of hyperkalemia and hyperphosphatemia V03AE
- Class
- Human
- Record last updated
- June 16, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| CALCIUM ACETATE | 667 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- February 21, 2007: NOC 8602New Drug Submission (NDS) · Manufacturer name change
- April 20, 2004: NOC 1639New Drug Submission (NDS) · Manufacturer name change
- September 19, 1996: NOC 4289New Drug Submission (NDS)